biomedicina slovenica


"Medical Oncology" : 201-300

  1. Micheli A; Coebergh JW; Mugno E; Massimiliani E; Sant M; Oberaigner W; Holub J; Storm HH; Pleško I; Pompe-Kirn V
    Eurpean health systems and cancer care
    2003
  2. Škof Erik; Grašič-Kuhar Cvetka
    Ovarian germ cell tumours: survival and fertility
    2003
  3. Huebscher Karmen; Oklješa-Lukič Aleksandra
    Zgodovina radioterapije na Onkološkem inštitutu v Ljubljani
    [History of radiotherapy at Institute of oncology Ljubljana]
    2003
  4. Oklješa-Lukič Aleksandra; Huebscher Karmen
    An outline of the history of radiotherapy at the Institute of oncology in Ljubljana from its beginning till 1980s
    [Pregled razvoja radioterapije na Onkološkem inštitutu v Ljubljani od pričetkov do osemdesetih let 20. stoletja]
    2003
  5. Škufca-Smrdel Andreja Cirila
    Experiencing professional strains of nurses, radiation engineers and physicians working at the Institute of oncology in Ljubljana
    [Doživljanje preobremenjenosti medicinski sester, radioloških inženirjev in zdravnikov na Onkološkem inštitutu v Ljubljani]
    2003
  6. Musek Matjaž; Oven Marjeta; Južnič Primož
    Ten years of the journal Radiology and oncology: some bibliometric evaluation
    [Deset let revije Radiology and oncology: nekaj bibliometrijskih izmer]
    2003
  7. Fras Peter Albert
    Onkološki inštitut v obdobju 1938-2002
    2003
  8. Paridaens R; Dirix L; Lohrisch C; Beex L; Nooij M; Cameron D; Biganzoli L; Čufer T; Duchateau L; Hamilton A; Lobelle JP; Piccart M
    Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer
    2003
  9. Lutz JM; Francisci S; Mugno E; Usel M; Pompe-Kirn V; Coebergh JW; Bieslka-Lasota M
    Cancer prevalence in Central Europe: the EUROPREVAL study
    2003
  10. Capocaccia R; Colonna M; Corazziari I; de Angelis R; Francisci S; Micheli A; Mugno E; Pompe-Kirn V
    Measuring cancer prevalence in Europe: the EUROPREVAL project
    2002
  11. Borisov Peter
    Josip Cholewa: 1885-1942
    2003
  12. Plesničar Stojan
    "Banovinski inštitut za raziskovanje in zdravljenje novotvorb v Ljubljani" - 65. obletnica
    2003
  13. Agrež Živa
    Amputacija Onkološkega inštituta?!
    2003
  14. Krajc Mateja
    Mutational analysis of the BRCA-1 and BRCA-2 genes in Slovenian families with a high incidence of breast and/or ovarian cancer and investigation of feasibility and the moral implications of counseling of these families in Slovenia
    2000
  15. Rudolf Zvonimir
    Prof. Božena Ravnihar, MD, PhD (1914-2002)
    2003
  16. Zupanič-Slavec Zvonka
    Jereb, Berta (Črneče, 25. 5. 1925), zdravnica onkologinja, radioterapevtka
    2002
  17. Fras Albert Peter
    Razvoj onkologije v obdobju 1938 do 2002
    2002
  18. Anonymous ;
    In memoriam: prof. dr. Božena Ravnihar, dr. med. 1914-2002
    2002
  19. Rudolf Zvonimir
    Uvodnik
    2002
  20. Fras Albert Peter
    Prof. dr. Božena Ravnihar (1914-2002)
    2002
  21. Štabuc Borut
    Fundacija "Docent dr. J. Cholewa"
    [Foundation "Docent dr. J. Cholewa"]
    2002
  22. Fidler V
    Ekspertno mnenje za opremljanje in razvoj PACS sistema na Onkološkem inštitutu v Ljubljani
    2002
  23. Skela-Savič Brigita
    Zadovoljstvo bolnikov - kazalec kakovosti v zdravstvu
    2002
  24. Matos Urška
    Obračun na onkologiji
    2002
  25. Čufer Tanja; Golouh Rastko; Noč Gorazd; Rudolf Zvonimir; Snoj Marko; Vardijan Rudolf
    Obračun na onkologiji
    2002
  26. Fras Albert Peter
    Odgovor Onkološkega inštituta
    2002
  27. Micheli A; Mugno E; Krogh V; Quinn MJ; Coleman M; Hakulinen T; Gatta G; Berrino F; Capocaccia R; Pompe-Kirn V
    Cancer prevalence in European registry areas
    2002
  28. Oven Marjeta
    Neznosna lahkotnost citiranja: primerjalna analiza citiranja raziskovalcev Onkološkega inštituta v reviji Radiology and Oncology in revijah, ki so zastopane v Science Citation Indexu
    [The unbearable lightness of citing: the comparative analysis of citations of researchers in Institute of Oncology (Ljubljana) in journal Radiology and Oncology and journals indexed in Science Citation Index]
    2002
  29. Skela-Savič Brigita
    Zadovoljstvo bolnikov - kazalec kakovosti v zdravstvu
    2001
  30. Rudolf Zvonimir
    Uvodnik
    2002
  31. Šamija Mirko; Juretić Antonio
    Zbornik radova 1. kongres Hrvatskog onkološkog društva; 2001 stu 28-30; Zagreb
    2001
  32. Lestan Alenka
    Karcinogeni na delovnem mestu pri zdravstvenih delavcih Onkološkega inštituta
    [Carcinogens at the workplaces of the personnel of the Institute of oncology]
    2001
  33. Tannock Ian
    Celostni onkološki center: pismo prof. dr. Iana Tannocka z Univerze v Torontu
    2001
  34. Zajec Diana
    In vendarle se premika: pogovor z doc. dr. Albertom Petrom Frasom, dr. med., direktorjem Onkološkega inštituta v Ljubljani, o novi stavbi in težavah z izrabljeno opremo
    2001
  35. Lešničar Hotimir
    Ali ta država ljubi raka?
    2001
  36. Rogelj Barbara; Rogelj Dušan
    Ozdraviti naš odnos do raka
    2001
  37. Koporc Alenka
    Ista bolezen ima lahko različne obraze
    2001
  38. Lestan Alenka
    Vpliv ionizirnega sevanja in citostatikov na karcinogenezo pri zdravstvenih delavcih onkološkega inštituta
    2001
  39. Lešničar Hotimir
    Izkušnje enoletnega pospecialističnega izobraževanja v tujini: pogovor s Primožem Strojanom in Janezom Žgajnarjem
    2001
  40. Golouh Rastko
    Uvodnik
    2001
  41. Jereb Berta
    Kje smo v onkologiji in zakaj?
    2001
  42. Jereb Berta
    Nekaj skromnih misli o mentorstvu, stroki in učenju
    2000
  43. Zwitter Matjaž
    Bela lisa na zemljevidu zdravstva: zanemarjena onkologija
    2001
  44. Čufer Tanja
    Celovita obravnava raka dojke
    2000
  45. Koporc Alenka
    Zdravnik mora bolniku vedno nakloniti tudi človeško besedo
    2000
  46. Colleoni Marco; Smith Heather; Castiglione-Gertsch Monica; Gelber Richard D; Sauerbrei Willi; Coates Alan S; Schumacher Martin; Bonetti Marco; Bastert Gunter; Lindtner Jurij
    Duration of adjuvant chemotherapy: a joint analysis of two randomized trails investigating 3 versus 6 courses of cyclophosphamide methotrexate and 5-fluorouracil (CMF) without endocrine treatment
    2000
  47. Zadravec-Zaletel Lorna; Bratanič Nevenka; Jereb Berta
    Endocrine late effects after treatment of childhood cancer
    2000
  48. Velenšek-Prestor V; Koželj M; Rakovec P; Jereb B
    Late cardiac damage of anthracycline therapy for acute lymphoblastic leukemia in childhood
    2000
  49. Borštnar Simona; Vrhovec I; Čufer Tanja
    Prognostic value of urokinase plasminogen activator inhibitors in cytosols from breast cancer patients
    2000
  50. Pajk Bojana; Čufer Tanja; Borštnar Simona; Zakotnik Branko; Us-Krašovec Marija
    Predictive value of DNA ploidy in elderly breast cancer patients treated with tamoxifen
    2000
  51. Jereb Berta
    Long-term follow-up of childhood cancer survivors
    2000
  52. Zwitter Matjaž
    Ethical issues in clinical research
    2000
  53. Čufer Tanja
    Update on breast cancer chemotherapy
    2000
  54. Primic-Žakelj Maja
    Breast cancer prevention trials
    2000
  55. Žgajnar J; Gatzemeier W; Costa A
    Will the sentinel lymph node (SLN) stand a second time - SLN biopsy in breast cancer patients with isolated local recurrence following breast conserving therapy and previous SLN procedure
    2001
  56. Čufer T; Bračko M
    Myeloid metaplasia of the breast
    2001
  57. Furlan R; Auersperg M; Šoba E
    COMBINED MULTIDISCIPLINARY APPROACH TO ADVANCED T3-T4, N0-N3 SQUAMOUS CELL CARCINOMA OF ORAL CAVITY AND OROPHARYNX
    1981
  58. Ludwig Group; Orel J; Benedik M; Hrabar B; Ferluga D; Rott T
    INTRAPLEURAL CORYNEBACTERIUM PARVUM AS ADJUVANT THERAPY IN OPERABLE (STAGE 1 AND 2) BRONCHIAL NON-SMALL CELL CARCINOMA; PRELIMINARY REPORT
    1979
  59. Strojan Primož
    Postspecialistični študij na Peter MacCallum cancer institute, Melbourne
    2001
  60. Debevec Miha
    Onkologija 21. stoletja
    2000
  61. Golouh Rastko
    Uvodnik
    2000
  62. Debeljak Andrej; Triller Nadja; Kecelj Peter
    The role of flexible bronchoscopy in the localised peripheral lung tumours
    2000
  63. Kecelj Peter; Debeljak Andrej; Triller Nada; Kern I; Osolnik K; Šorli J
    Bronchoalveolar lavage in patients with lymphangiocarcinimatosis of the lung
    2000
  64. Šikić Branimir J; Šamija Mirko
    CEOC 2000. Program and abstract book of the 2nd central European oncology congress; 2000 Jun 27-30; Opatija
    2000
  65. Žakelj Bronja; Koporc Alenka
    Prihodnost Onkološkega inštituta kot izziv
    1995
  66. Čufer T
    Adjuvant therapy of breast cancer: update
    1999
  67. Primic-Žakelj M
    Screening mammography for early detection of breast cancer
    1999
  68. Ravnihar Božena
    Ob 50-letnici Onkološkega inštituta v Ljubljani: kratka zgodovina njegovega razvoja
    1988
  69. Snoj Marko
    Gradnja novega Onkološkega inštituta zastaja
    2000
  70. Zupanič-Slavec Zvonka
    Berta Jereb: zdravnica radioterapevtka onkologinja (1925): velika botra otroške onkologije
    [Berta Jereb: a pioneer of paediatric oncology]
    2000
  71. Zakotnik Branko
    Difficult decisions in medical oncology
    2000
  72. Ećimović Patricija
    Medical graduates in oncology
    2000
  73. Zwitter M; Ećimović P
    Advanced course on ethics in oncology: program and course material; 2000 Jun 25-28; Bled
    2000
  74. Anonymous ;
    Reading, writing and randomised trials - getting the most from publishing and publications. An ESMO course; 1999 Oct 27-30; Budapest
    1999
  75. Zwitter Matjaž
    Ethical considerations in publishing data and the ethics of the editorial process
    1999
  76. Tomšič Radka
    Prognostic factors in patients with non-Hodgkin's lymphoma of the head and neck in stage I and II
    1999
  77. Zabric Vida
    Pot k okrevanju - 15 let delovanja v Sloveniji
    1999
  78. Vegelj-Pirc Marija
    Psihoonkologija: 15 let delovanja Oddelka za psihoonkologijo na Onkološkem inštitutu Ljubljana
    1999
  79. Vegelj-Pirc Marija
    1984-1999 spremna beseda urednice zbornika
    1999
  80. Piškur-Kosmač Dunja
    Ob 15. obletnici Oddelka za psihoonkologijo in programa Pot k okrevanju
    1999
  81. Čufer T; Lazarev A; El-Ghamrawy K; Doval D; Vrba Z; Shah P; Kurtova A; Ghilezan N; Chalofti I; Blanc C
    Preliminary data of a phase II trial of taxotere (TXT) 100 or 75 mg/m2 as 2nd line chemotherapy (CT) in patients (pts) with metastatic breast cancer (MBC) with stratification according to prognosis factors
    1998
  82. Bambič Matevž
    Analiza odnosov v zdravstvu in na Onkološkem inštitutu
    1996
  83. Bambič Matevž
    Onkološki inštitut - strateško načrtovanje in management
    1996
  84. Karrer K; Eržen J; Hrabar B; Debevec M; Klevišar M; Rott T; et al ;
    The role of ifosfamide and cyclophosphamide in the multi-modality treatment after surgery for cure for small-cell bronchial carcinomas (SCLC)
    1989
  85. Goldhirsch A; Eržen D; Cerar O; Štabuc B; Golouh R; Lamovec J; Šebek S; Kramberger M; Vrhovec I
    Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International breast cancer study group (IBCSG) trial VI
    1997
  86. Stanovnik M; Čufer T; Borštnar S; Pajk B
    Clinical study with interferon alpha-2A and cis-retinoic acid (CRA) in metastatic cancer of the kidney
    1998
  87. Therasse P; Mauriac L; Welnicka M; Bruning P; Čufer T; Tomiak E; Curran D; Ramirez A; Koopmanschap M; Piccart M
    An EORTC-NCIC-SAKK neoadjuvant randomized phase III study comparing CEF (5FU, epirubicin, cyclophosphamide) vs dose intensified EC+G-CSF (filgrastim) in locally advanced breast cancer (LABC): updated results including quality of life
    1998
  88. Pajk B; Čufer T; Zakotnik B; Borštnar S; Us-Krašovec M
    DNA ploidy as a predictive factor of tamoxifen treatment in elderly breast cancer patients stage I-III
    1998
  89. Ocvirk J; Štabuc B; Čurin V; Žumec P
    Serum TNF-alpha and soluble TNF receptors p55 in melanoma patients
    1998
  90. Lindtner Jurij
    Spoštovana bralka, cenjeni bralec
    1998
  91. Rudolf Zvonimir
    Uvodnik
    1998
  92. Rudolf Zvonimir
    Oris Onkološkega inštituta: iz govora na svečani akademiji
    1999
  93. Rudolf Zvonimir; Čufer Tatjana; Kiauta Dušica; Kovač Vilijem; Serša Gregor
    Onkološki inštitut Ljubljana 60 let: 1938-1997: poročilo
    [Institute of oncology Ljubljana 60 years: 1938-1997: report]
    1998
  94. Kiauta Dušica; Bavec Marija; Podgoršek Milena; Štrukelj Breda; Tomšič Radka
    Bibliografija delavcev Onkološkega inštituta v Ljubljani 1993-1997
    [Bibliography of the staff of the Institute of oncology Ljubljana 1993-1997]
    1998
  95. Roth Anton
    In memoriam: prof. Krsto Kolarič
    1996
  96. Borisov Peter
    Docent dr. Josip Cholewa, prvi predstojnik Onkološkega inštituta v Ljubljani
    1998
  97. Golouh R
    Onkologija: uvodnik
    1997
  98. Raemaekers J; Burgers M; Henry-Amar M; Pinna A; Mandard A; Monfardini S; Hagenbeek A; Breed W; Carde P; Vovk M
    Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have ecxellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG AND GPMC phase III trial
    1997
  99. Goldhirsch A; Gelber RD; Castiglione M; O'Neill A; Thurlimann B; Rudenstam C-M; Lindtner J; Collins J; Forbes J; Crivellari D
    Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International breast cancer study group (IBCSG) trial VI
    1997
  100. Snoj M
    Začetek gradnje Onkološkega inštituta
    1997

   1 101 201 301  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics